Journal
CANCER INVESTIGATION
Volume 27, Issue 6, Pages 682-690Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/07357900802620893
Keywords
Yttrium-90; Microsphere; Liver; Choroidal; Melanoma; Metastases; Uveal; Hepatic; Brachytherapy
Categories
Ask authors/readers for more resources
Background: Ocular melanoma (OM) metastasizes to the liver and is rapidly fatal despite aggressive therapy. Yttrium-90 microspheres (radioembolization) delivered via the hepatic artery is an established and effective approach for primary and metastatic hepatic tumors, although 90Y use in OM has not been reported previously. Methods: A retrospective review was performed for all patients with OM who received radioembolization at 5 centers. Results: 11 patients received 12 treatments with a median activity of 1.55 GBq delivered per treatment. Toxicity was minimal, with PET/CT at 3 months posttreatment showing a response in all patients; 1 patient had a complete response. Conclusions: Radioembolization can control hepatic metastases of OM with very few side effects.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available